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Tissue Engineering of Lips and Muco-Cutaneous Junctions:
In Vitro Development of Tissue Engineered Constructs
of Oral Mucosa and Skin for Lip Reconstruction
Antonio Peramo, Ph.D.,1 Cynthia L. Marcelo, Ph.D.,2 and Stephen E. Feinberg, D.D.S., M.S., Ph.D.1,2
We report for the first time the fabrication of a three-dimensional tissue structure containing, in a continuous
layer, the morphological features of a lip: epidermal skin, vermillion, and oral mucosa. This tissue engineered
muco-cutaneous (M/C) equivalent was manufactured using human oral and skin keratinocytes grown on an
acellular, nonimmunogenic dermal equivalent (AlloDerm) to produce a tissue equivalent with similar anatomic
and handling properties as native human lips. Confirmation of the structural composition of the construct was
performed using routine histology and immunohistochemistry by identification of epithelial markers that are
differentially expressed in separate anatomic areas of the lips. These full-thickness human lip skin equivalents
can be used in surgical lip reconstruction in individuals suffering from lip loss from cancer, congenital defor-
mations, and injuries after accidents. We propose this technique can be used as a general basis for tissue
engineering of M/C junctions in other parts of the body, such as anus and vagina.
Introduction
Adifficult structure of the face to reconstruct aftersurgery or avulsion is the lips because they represent a
composite tissue of mucosa, skin, and muscles1–3 Significant
loss of lips is a functional and esthetic concern because the
neuromuscular control of normal lip structures is required
for activities of eating, drinking, talking, and social gestures.
Avulsion or partial loss of the lips is a survivable injury but
without functional lip reconstruction life for injured indi-
viduals is burdened by drooling, food spillage while eating,
unintelligible speech, and social rejection. Functional recon-
struction of the lips is so important that when greater than
50% of the lips are avulsed face transplantation under life-
time immunosuppression becomes an option.
Tissue engineering and regenerativemedicine offer a unique
opportunity to create composite tissue structures in the area
of soft tissue reconstruction with tissue units with a muco-
cutaneous (M/C) junction such as the lip. Several models of
in vitro bioengineered human skin4,5 and oral mucosa6–8 have
been developed to date but separately used in applications to
repair, respectively, skin and oralmucosa. Thesemodels can be
classified in different ways: by the anatomical structure they
target (epidermis, dermis, or both), by the type of materials
used (biological, synthetic), by the cellular component present
in the composite (cellular or acellular), or by the technique
(in vitro, in vivo).9–11 These bioengineered tissue equivalents are
developed to address epidermal, partial thickness, and full
thickness injuries and so the approach to use them is differ-
ent.12 Several products are currently commercially available
and have been extensively described.5 None of them, however,
present a tissue composite with a M/C junction. For this rea-
son, development of continuous human oral mucosa-lip-skin
constructs or with other M/C junctions is necessary. The oral
mucosa forms the inner aspect of the lip and extends and unites
with the skin by a junction known as the vermillion border that
unites the oral mucosa with the skin of the face.13,14
Here we report for the first time the fabrication of a M/C
tissue engineered construct in vitro. The process consists of
growing human oral and skin keratinocytes into a three-
dimensional (3D) construct to form a M/C junction con-
taining stratified oral mucosa and stratified skin on the same
dermal component. This 3D lip construct contains all func-
tional areas of the epithelium of the human lip and can be
used as the basis for the fabrication of vascularized pre-
laminated flaps for full lip reconstruction or for repair of the
lips when both the oral and epidermal areas require tissue
replacement. In addition, this technique can be extended to
other anatomic areas for the repair of tissues where a M/C
junction is present, including the nares, eyelids, vagina, and
others. Cancer patients are one group of patients who will
also benefit since cancer surgery leaves complicated defects
that can be repaired using this type of technology, and
treatment of developmental defects in children.
The manufacture of the M/C constructs is based on a
technique previously reported by Izumi et al15 where oral
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keratinocytes were used to prepare human oral mucosa en-
gineered constructs termed ex vivo produced oral mucosal
equivalents (EVPOME) consisting of a dermal component
with AlloDerm, (LifeCell, Branchburg, NJ) that is seeded
with autologous human oral keratinocytes to form an over-
lying stratified parakeratinized or nonkeratinized epithelial
layer.
Materials and Methods
Fabrication of 3D lip constructs
We used previously frozen oral and skin adult human
keratinocytes to fabricate a composite EVPOME. Full thick-
ness human skin (from a breast reduction) and oral mucosa
explants (taken from the upper inner aspect of the lip) that
came from two different individuals obtained from dis-
carded material from surgeries performed at the University
of Michigan Health System. The Institutional Review Board
approved use of the mucosa and skin, and donors provided
informed consent for research use. Preparation of the ex-
plants and extraction of keratinocytes was performed as
previously reported by Marcelo16 for skin and by Izumi
et al17 in the case of oral mucosa. Tissue samples were di-
gested with a 0.04% trypsin solution (oral tissues) or 0.125%
trypsin solution (skin tissues) overnight at room temperature
(Sigma-Aldrich, St Louis, MO). Enzymatically dissociated
keratinocytes were plated at a density of 7.0 · 106 cells per
T-25 flask (Corning, Corning, NY). The cells were cultured
without a feeder layer, fetal bovine serum, or bovine pitui-
tary extracts in an animal product-free culture medium,
EpiLife M-EPI-500, (Cascade Biologics, Portland, OR) that
was supplemented with EpiLife defined Growth Supplement
(EDGS; Cascade Biologics). In addition, the medium was
supplemented with 25 mg/mL of Gentamicin (Sigma-
Aldrich) and 0.375mg/mL of Amphothericin B (Gibco,
Invitrogen Carlsbad, CA). Primary keratinocytes were har-
vested when 70%–80% confluent and were subsequently
subcultured for use in the fabrication of EVPOMEs. In these
techniques, both oral and skin keratinocytes are expanded in
a serum-free defined low calcium medium (0.06mM CaCl2).
The primary oral and skin keratinocytes were cultured
and grown in separate culture flasks and passaged to reach
passage 2 and then frozen. Afterward, they were thawed and
cultured to reach the necessary number of cells for seeding
on the dermal allograft, at a density of 2.5 · 105 cells/cm2.
This portion of the manufacturing protocol can vary in time
and is mostly dependent on the need for oral keratinocyte
amplification given that the oral explants are typically
smaller. The number of keratinocytes necessary for fabrica-
tion of the 3D lip construct must be calculated because it is a
function of the size of the surgical site grafting. The Allo-
Derm was presoaked in 5mg/cm2 human type IV collagen
(Becton Dickinson Labware, Bedford, MA) for a minimum of
3 h before keratinocyte seeding. Once a sufficient number of
both skin and oral keratinocytes had been grown in culture
flasks, they are seeded in two separate compartments on the
same piece of type IV collagen coated AlloDerm to create
an interface between the two keratinocyte populations
(Fig. 1B). In the experimental protocol reported here, pas-
sage 3 cells were used for seeding in the 3D lip constructs.
The basic features of the procedure are represented in
Figure 1. Figure 1A visualizes the concept behind the con-
struction of the tissue engineering equivalent. The 3D lip
construct consists of two areas separated by a removable
barrier that can be made of varied thicknesses and manu-
factured using a biocompatible polymeric material, poly-
dimethylsiloxane (PDMS; Sylgard 184 Dow Corning) (Fig.
1B). On one side skin keratinocytes were seeded and on the
other side oral mucosa keratinocytes were seeded at the
same concentration. It is convenient to resuspend the cells in
low volumes of medium (125mL) and carefully distribute
them across the surface of the AlloDerm to allow them to
quickly settle for 30- to 45min and then raise the medium
volume. The intermediate area, the future vermillion border,
FIG. 1. (A) This picture helps visualize the concept behind the construction of the three-dimensional (3D) lip tissue engi-
neering construct. The inner aspect of the lip is made of oral mucosa and the outer aspect is made of epithelial cells. They
form a muco-cutaneous junction at the vermillion. (B) Schematic of the system for the preparation of the 3D lip construct. The
cells are seeded over an Alloderm membrane temporarily divided (overnight) by a removable barrier made of poly-
dimethylsiloxane (PDMS). After a few days in culture the whole construct is raised to the air/liquid interface to become a 3D
organotypic construct. (C) Diagrammatic representation of the components of the muco-cutaneous junction of a lip. Oral and
skin cells mingle in the vermillion. Color images available online at www.liebertonline.com/tec
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was of a thickness equal to that of the removable barrier,
3mm, remained without cells. The barriers were left in situ
overnight and lifted the next day allowing the cells of the
skin and oral areas, by migration, to come into contact to
form the underlying basic lip structures (Figs. 1C and 2D,
right).
The AlloDerm composite with the seeded cells was then
cultured and submerged for 4 days, during which time they
migrated to form a continuous epithelial monolayer. After
that period, the concentration of calcium in the culture me-
dium was raised to 1.2mM to enhance keratinocyte differ-
entiation.18–20 After 4 more days of culture in submersion at
1.2mM calcium concentration, the 3D lip constructs were
raised to the air-liquid interface and maintained for 7 days to
encourage stratification of the epithelial monolayer, for a
total of 15 days. This resulted in a 3D construct with two
stratified epithelial components, epidermal and oral. It
should be noted that the number of days in this protocol are
flexible and needs to be adjusted to the size of the AlloDerm
needed for reconstruction to allow enough time for cellular
migration to form the vermillion.
In a separate and preliminary experiment, a 3D construct
was fabricated in which no migration period was allowed
and where the cells in the two areas did not migrate because
they were maintained in 1.2mM calcium medium from the
beginning of the experiment and the submersed incubation
time was only 4 days. In this special case, the oral cells used
came from the masticatory mucosa of the alveolar ridge
which has a keratinization profile similar to that of skin.
Materials and components design
AlloDermmembranes coated with type IV collagen were
placed in a 2 cm diameter Transwell carrier system (shown at
the bottom of Fig. 2D for illustration purposes). The barriers
(also pictured in Fig. 2D) were made of acrylonitrile buta-
diene styrene (ABS) plastic (yellow) using fused deposition
modeling with a Dimension Elite FDM 3D Printer (Stratasys,
Eden Prairie, MN) available at the University of Michigan 3D
Lab, a system that is used to print functional models of parts
such as medical devices. The barriers work as a mold, are put
inside a Petri dish and PDMS is poured and then cured (left
image, Fig. 2D). After curing, the barriers with the PDMS
are retrieved and can be used for the experiments as is.
Another option is to retrieve the cured PDMS molded in the
space between the plastic barriers and directly use it. Both
options were successfully tested in our experiments but it
was easier to handle the combined plastic barriers with the
PDMS rather than the PDMS alone. The yellow plastic bar-
riers were designed with a small handler on top to allow
easier manipulation. In these experiments the PDMS pro-
vided a temporary hydrophobic membrane to separate cell
FIG. 2. Before using Alloderm, in preliminary experiments, oral (*) and skin keratinocytes (+ ) were seeded in Petri dishes
with a PDMS barrier (black line in upper right quadrant) to determine whether they will mingle and form the equivalent of a
vermillion. (A) Initial seeding, (B) oral and skin keratinocytes advancing fronts ‘‘mix’’ in the middle to form a ‘‘vermillion’’
after migrating in the center of the Petri dish, and (C) fixed and stained oral and skin keratinocytes after 6 days in culture
showing confluence and ‘‘mixing’’ of two cell populations. We experimented with barriers of varied thicknesses and lengths
to separate the areas where the cells would be seeded to adjust to the sizes of Petri dishes (D, left) or six-well cultures (D, right
pictured without the barrier with the central area indicated with black lines). The process is explained in the sequence of
imageD. The plastic barrier is filled with PDMS in a separate container to allow curing of the PDMS and then used by placing
it to adjust over the Alloderm (tissue at the bottom in center D) and the container. The barrier shown in D works as a mold
to pour the PDMS but several variations of this technique can be implemented to fit the needs of the researcher or to adjust to
clinical applications. Color images available online at www.liebertonline.com/tec
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populations seeded on each side of the barriers. The barrier is
placed over the AlloDerm (center image, Fig. 2D) exerting a
slight pressure to secure the barrier and to prevent sub-
stantial transfer of the cell containing medium from one area
to the other. It should be noted, however, that the barriers
used cannot provide a complete seal to prevent liquid
transfer because exerting too much pressure will compress
the AlloDerm. As can be seen in our results, liquid ex-
change between the two areas did not prevent the formation
of the full construct. Given that the polycarbonate membrane
of the Transwell carrier is too weak and thin to withstand
any pressure without breakage, we found that the easiest
way of seeding the cells on the AlloDerm without cell
mixing would be to use small six-well plates or similar sized
Petri dishes (Fig. 2D right). The constructs and cells are then
cultured, submersed, in these plates until the time they are
transferred to the air-liquid interface carrier.
Preliminary evaluation of the formation
of a cellular M/C junction
Before using the AlloDerm, a preliminary experiment
was designed where oral keratinocytes from the inner aspect
of the upper lip and skin keratinocytes were seeded, without
AlloDerm, directly on regular cell culture treated Petri
dishes divided in half by a PDMS barrier, as described ear-
lier. After cell seeding and after removal of the barrier the
next day, keratinocytes were culturedand submersed for a
total of 6 days. At the end of this period the cells were fixed
with 95% ethanol and stained with Coomassie Blue before
light microscopy evaluation.
Keratinization profile of the seeded cells
The cells dissociated from the tissues and amplified for use
in the 3D lip constructs were separately analyzed for epithelial
markers to determine their keratinization profile. In addition,
and for comparison, oral mucosa cells taken from the cheek
were also studied for keratin expression because this area of
the oral mucosa, the cheek, shows an in vivo keratinization
profile similar to that of the inner aspect of the lip21,22 and,
thus, can be used as an alternative source of the cells. The
cheek cells were not used in the Alloderm experiments.
After trypsinization and centrifugation, an aliquot of the
cells (at passage 3) that were seeded on the constructs (and
the cheek cells) were resuspended in EpiLife medium and
cytospun at 750 rpm for 5min in a ThermoShandon Cytopsin
(ThermoSahndon, Pittsburg, PA using Shandon Cytoslide
and ThermoShandon single cytology Funnel, from Fisher
Scientific, Pittsburh, PA). Afterward the cells were fixed and
maintained in 95% ethanol until immunohistochemical
analysis was performed. The cytokeratins evaluated were K4
(mouse monoclonal, dilution 1:100; Abcam, Inc., Cambridge,
MA); K10 (mouse monoclonal, dilution 1:200; Novus Biolo-
gicals, Littleton, CO); K13 (mouse monoclonal, dilution
1:100; Abcam, Inc.); and K19 (mouse monoclonal, dilution
1:100; Vector Laboratories, Burlingame, CA).
Evaluation of 3D lip manufactured constructs
Fifteen days after initial culture the 3D lip constructs were
fixed in 10% phosphate buffered formalin and the morpho-
logical features evaluated by optical microscopy with routine
tissue staining techniques (hematoxylin and eosin [H&E]). In
addition, immunohistochemical markers were used to iden-
tify the epidermal and oral cell populations in the different
areas of the M/C construct. Our initial focus was in identi-
fying K10 positive and K4, K13, and K19 negative areas for
the skin part and the opposite for the oral mucosa part.23,24
Results
Preliminary evaluation of the formation
of a cellular M/C junction in vitro
Before attempting to manufacture the 3D lip construct we
evaluated whether the cells would form the cellular equiv-
alent of a M/C junction in vitro. We observed (Fig. 2A–C)
that both cell strains, after 6 days of culture, formed an ad-
vancing front from the original seeding area and mingled
and contacted at several points along the division where the
barrier was located (which would be the equivalent of the
vermillion in vivo).
Observation of cellular growth and migration during
initial phase of 3D construct preparation
For the size of our constructs and concentration of cells
used we found that a period of 3–5 days of preliminary
culture in submersion would allow cell migration to form the
interface or vermillion, but this is a parameter that needs to
be adjusted to the specifics of the experimental setting.
In the technique presented, where the AlloDerm is
smaller than the size of the six-well plate, we found there is
enough space in the areas around the AlloDerm to follow
and observe keratinocyte expansion, migration, and differ-
entiation during the time they are submersed in the six-well
plates and before transfer to the air-liquid interface. This
actually permits the person controlling the experiment to
make the decision of when to increase the calcium concen-
tration to 1.2mM to start the differentiation process. This
sequence is shown in Figure 3. We found that, effectively,
both cell strains advanced at the bottom of the well plate and
also on top of the AlloDerm. Obvious phenotypic changes
occurred when the calcium in the medium was raised to
1.2mM, as observed when comparing Figure 3D, E where
keratinocytes changed from a small, polygonal shape with a
mosaic pattern to a larger more irregular shape with a den-
sely packed and stratified distribution.
Structure of the 3D lip constructs
The morphology of the construct replicates a continuous
3D skin-mucosal artificial structure with well-defined mu-
cosal lip (no granular layer) section (right part of Fig. 4) and a
clearly identifiable skin section (left part of Fig. 4). The full
3D lip construct showed normal epidermal stratification
several cells thick. We were not able to clearly identify the
section corresponding to the vermillion or transitional area
solely by observing the H&E sections, but this transition was
easily identified with the cytokeratin markers.
Keratinization profile of the cytospun cells
Cytospun cheek cells and, at the time of seeding on the
Alloderm, oral lip cells, did not express keratin 4 while
most skin cells lacked keratin 10 (Fig. 5). This was in clear
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contrast to the expression of these cytokeratins in their re-
spective native tissues, as seen observing the images in Fig-
ure 4. On the other hand, both cytospun oral cells showed
strong expression of the basal cell marker keratin 19 and the
suprabasal cell marker keratin 13. Broadly, these results in-
dicated that some of the keratins expressed in vivo in oral
tissues are lost or show reduced expression at the time of cell
seeding when manufacturing the 3D constructs. This is
summarized in Table 1 where a basic analysis of the keratin
expression found in the 3D constructs, native tissues and
cells is presented.
Keratinization profile of the 3D lip constructs
The keratinization of the constructs is clearly seen in the
magnified images of Figure 6. The top image shows a full
construct where strong presence of keratin 10 was supraba-
sally observed but gradually decreases and finally dis-
appeared in the oral portion of the constructs. Conversely, in
the oral portion, very clear presence of keratin 19 and light
presence of keratin 13 was noticed. Keratin 4, which is
strongly present in oral labial mucosa, was not observed in
any area of the constructs probably because this depends on
the thickness of the epidermal layer formed above the Allo-
derm. The area where keratin 10 started to disappear and
keratin19 was present represents the vermillion which in
native tissue is devoid of hair and glands and lacks a cor-
nified layer.
Structure of a 3D lip construct without cell migration
When the time during which the cultures were submersed
was reduced to 4 days using only 1.2mM calcium medium
(instead of using 4 days submersion in low calcium plus 4
days submersion in 1.2mM calcium) it was observed, as
expected, that the cells did not migrate after raising the
construct to the air-liquid interface and the intermediate area
did not show any cell ingrowth (Fig. 7). Alveolar ridge cells
formed a keratinized construct, similar to the one seeded
with skin cells, with strong presence of cytokeratin 10.
Discussion
With the broad objective of developing a technique for the
construction of M/C junctions, we have shown that in vitro
reconstruction of the skin and mucosa of the lips is feasible
using a simple tissue engineering method combined with
FIG. 3. A technique to help control on which day the 3D lip construct should be raised to the air-liquid interface is shown in
the sequence of pictures in this figure. In all pictures the Alloderm (indicated with an *) with the cells is cultured in a six-well
plate whose dimensions are bigger than the construct (see Fig. 2E). Two (A) and 3 (B) days after cell seeding the cells (skin on
the left, oral on the right) can be seen growing and migrating on the bottom of the well, toward each other, in the direction
indicated by the arrows. At 5 days (C) the gap has closed. This provides a good visual indication of cell migration on the
Alloderm itself and could be used as a predictor of the formation of the vermillion. The cells form a packed monolayer while
cultured with low calcium medium (D), but clearly change to a differentiated cell phenotype after changing the culture
medium to 1.2mM to induce keratinocyte differentiation (E, picture taken 24 h after medium change). After 4 more days in
culture in these conditions, the 3D lip construct is then raised to the air-liquid interface to allow epidermal stratification. Color
images available online at www.liebertonline.com/tec
TISSUE ENGINEERING OF LIPS AND MUCO-CUTANEOUS JUNCTIONS 277
basic epithelial cell culture techniques. We combined a
commercial and widely used clinical dermal substitute
(AlloDerm) with a known procedure that allows the dif-
ferentiation, in vitro, of keratinocytes from donor skin and
oral mucosa. By temporarily using a biocompatible poly-
meric barrier to separate the cell population during the time
required to ensure cell seeding over the dermal substitute,
we allowed the formation of a full M/C 3D structure con-
taining all three regional lip areas. This construct can then be
used as the basis for the fabrication of a vascularized pre-
laminated flap for the repair of the lips or for epithelial repair
of areas affecting both skin and lips. In our experiments, the
size of the 3D lip constructs were the equivalent of 1/3 of
the linear dimension of a upper human lip (Fig. 1A), but the
technique can be expanded to a full lip or even to manu-
facture both upper and lower lips.
Functional skin equivalents have been reported and pre-
viously used in clinical applications for treatment of burns
and chronic wounds.13 In addition ex vivo produced oral
mucosal equivalents have been fabricated25 and grafted into
humans.26 However, they have been separately implemented
and the oral constructs have only been used for intraoral
grafting procedures. The keratinization profiles of skin and
oral epithelia have been extensively documented previously
but mostly in separate accounts.22–23,27–29 However, evalua-
tion of the differentiation profile of the human lips had been
reported in a handful of occasions, particularly by Binnie14
and Barrett.30 Both groups showed clear differences in the
FIG. 4. The 3D construct
shows the typical aspect of
artificial epithelial replace-
ments, both the oral and skin
part, as observed in the mag-
nified images. It should be
noted however that the tran-
sitional area/vermillion can-
not be identified solely using
hematoxylin and eosin and it
was necessary to identify its
approximate location using
the keratin markers k10 and
k19 (see Fig. 6). Color images
available online at www
.liebertonline.com/tec
FIG. 5. To assess changes in
the keratinization profile of
the seeded cells the presence
of cytokeratins 19, 13, 4, and
10 was investigated. The cells
shown are mucosal lip (first
row), breast skin (second
row), and mucosal cheek
(third row). For reference,
sections of labial mucosa and
breast skin are also shown.
Changes in the keratinization
profile are most evident in
the lack of keratin 4 in lip
(compared to the tissue
counterpart) and cheek cells
and lack of keratin 10 ex-
pression in breast skin cells
(compared to the breast skin
tissue sections). Qualitatively,
we found that cultured cells
varied their keratinization
profile with the passaging
number and storage (freez-
ing) (see Table 1 for addi-
tional information) but that
keratin expression may re-
cover during EVPOME
reconstruction, as seen in
Figure 6. Color images
available online at www
.liebertonline.com/tec
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differentiation profile of the stratified squamous epithelium
of the lips and separated them by areas: orthokeratinized
epidermis, vermilion, intermediate zone (which is absent in
juvenile lips) and nonkeratinized, or sometimes para-
keratinized, labial (buccal) oral mucosa. The studies pre-
sented by these authors were based on the analysis of whole
tissue sections from human tissues, whereas in our case we
fabricated tissue equivalents in vitro.
Given that our focus is lip reconstruction as a model for a
more generalized tissue engineered M/C junction, an im-
portant part of our work was focused on the analysis of the
keratinization of the oral part of the 3D construct, to de-
termine whether it maintained, in vitro, a similar keratini-
zation profile as that of the buccal mucosa, which composed
the inner aspect of the lips. The buccal mucosa is formed by
the inner aspect of the lip, the cheek, and the retromolar
trigone. In contrast, the gingival and hard palate (mastica-
tory mucosa) show keratinization profiles similar to that of
skin.23 For this reason, except in one preliminary experi-
ment, we always used keratinocytes obtained from oral
tissues from the inner aspect of the upper lip (labial) as the
cells used in the constructs. While in clinical applications it
may be possible (but not always) to obtain biopsies from
facial skin of the affected area; this was not possible in our
work and we used keratinocytes derived from breast re-
ductions. The keratinization profiles of the skin part of the
constructs (Figs. 5–7) indicated that, in vitro, the skin part of
these M/C junction constructs could probably be grown
out of disparate skin areas.
For the above reasons, we focused our immunohisto-
chemical analysis on the most prominent differences ob-
served in epithelial markers present or absent in different
areas of the construct. Given that cells may change their
keratinization profile during the time they are frozen or
cultured for expansion and then trypsinized, we also per-
formed an additional analysis of the keratinization profile of
the cells that were seeded onto the Alloderm. We looked for
epithelial markers that are known to be selectively expressed
on each area and selected keratin 10 as positive indicator of
skin cells and the skin portion of the construct and keratins
K4, K13, and K19 for the oral keratinocytes and oral mucosa
portion of the construct. K10 is a marker of normal skin
differentiation and is suprabasally expressed on epithelial
tissues as are K4 and K13 on buccal mucosa, while K19 is
expressed by basal cells in nonkeratinized oral mucosa.
Keratin 13 expression is normally limited to nonkeratinizing
squamous epithelia and expression in skin is, together with
the expression of keratins 4 and 19, uncommon and assumed
to be a sign of re-induction of an embryonic type of differ-
entiation.31,32 All of them are cytoplasmatic markers.
Interestingly, as shown in Figure 5, we found that, at the
time of seeding, very few cytospun skin cells showed pres-
ence of keratin 10 and cytospun oral cells did not show the
presence of keratin 4. However, there was a full recovery of
Table 1. Short Summary of the Keratinization Profile Observed in Cells, Oral and Skin Specimens
and Three-Dimensional Muco-Cutaneous Lip Constructs
Notes K4 K10 K13 K19
Cytospun
oral lip cells
From previously
frozen lip cells
and seeded on
3D lip construct
Negative (1 or 2
cells positive)
Negative Present in around
10% of cells
Present in around
70%–80% of
cells,
particularly big
size cells
Cytospun
skin cells
From previously
frozen breast
skin cells and
seeded on 3D
lip construct
Negative Present in around 2%
of cells, mostly big
size cells
Negative Negative
Oral cheek
cells
Never frozen cells Negative (1 or 2
cells positive)
Negative (1 or 2 cells
positive)
Present in 15% of
the cells, mostly
big size cells
Present in around
40% of cells,
particularly big
size
Skin Breast skin
section
Negative Strong positive
suprabasally
Negative Negative
Labial
mucosa
Native oral lip
tissue section
Strong positive
suprabasally
Negative Strong positive
suprabasally
Positive only in
basal layer
3D lip
constructs
Fabricated with
deposited lip
and skin cells
Negative in all
areas of the
construct
Strong suprabasal
presence on the
skin side,
expression
vanishing toward
the oral side
Dim staining in
the oral part,
negative in the
rest
Positive in basal
cells oral part,
negative in rest
Observations were made for cytokeratins 4, 10, 13, and 19. Compared to native tissue K4 disappears in oral mucosa cells from lip and cheek
and was not observed in the 3D lip constructs. It was also noticed that previously frozen breast skin cells lost most of their keratin 10
expression. In contrast, keratin 13 and keratin 19 were observed in both cheek and lip cells but the percentage of cells expressing both markers
was much higher in lip cells. Interestingly keratin 19 was present in a high percentage of the cytospun oral lip cells. Both keratin 19 and 13
were observed in the oral part of the 3D lip construct. In essence, the keratinization profile may change with the typical processing during cell
culture but may recover during the time the cells are cultured on top of the AlloDerm.
3D, three-dimensional.
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K10 expression on the skin portion during incubation of the
cells on the Alloderm, indicating a healthy normal differ-
entiation process. K19 and K13 expression was strongly
maintained in the cytospun cells and noticed in the 3D lip
constructs. We did not observe recovery of cytokeratin 4 in
the constructs perhaps due to a limited epidermal cell
thickness in the oral portion. The differentiation of the ker-
atinocytes during the period they were cultured at the
air-liquid interface (7 days) permits the formation of an
epidermis two to three cells thick and keratin 4 in oral mu-
cosa is seen above the third or fourth cell layer (Fig. 5).
Additional confirmation that the 3D construct has the fea-
tures of a lip was found when keratin 10 was not found in
the oral section of the construct and keratin 19 was only
expressed in the basal layer of the oral section of the con-
struct as seen in Figure 6. These temporary and/or reversible
changes in the keratinization profiles of natural and bioen-
gineered oral mucosa constructs have also been previously
reported 33 and also have been shown in mice.34
While our focus was in the fabrication of a construct in-
corporating labial mucosa cells, a preliminary experiment
using cells taken from the alveolar ridge area of the mouth,
which is keratinized and similar to skin, indicated that it is
also possible to make tissue engineered M/C junctions with
skin and keratinized mucosa (Fig. 7). This option opens up
the possibility of creating composite tissues to repair any two
(or even more) different areas of mucosas, keratinized
(masticatory) and nonkeratinized and other combinations of
epithelial tissues that have not been attempted so far. In fact,
this will only require a redesign of the barriers.
The technique presented in this manuscript was developed
to adjust to the size of currently available commercial mate-
rials to grow tissue engineering constructs at the air-liquid
interface. For this reason the total dimensions of the 3D con-
structs represent a relatively small area of a human lip, as
suggested in Figure 1. Extension to bigger experimental
models will not represent a problem. A great advantage of the
model presented is that the construct is fully functional and all
materials used are already approved for clinical use.
FIG. 6. Immunohistochemical analysis of the 3D skin lip
construct for keratins K13, K19, K4, and K10. In the top
image, keratin 10 is seen decreasing (in the direction of the
arrow) from a strong expression in the skin area, dis-
appearing toward the oral part. A magnified view is pre-
sented in the second row. Keratin 19 (third row) is clearly
seen (arrow) in basal cells of the oral part of the lip construct
and is absent in the skin part. Both K13 and K4 were also
negative in the skin areas of the construct. K13 and K4,
which are strongly present in the native tissue, as shown in
Figure 5, are only lightly present (K13) or absent (K4) in the
construct. At this stage in the development of the in vitro lip
substitutes it appears that the best markers to identify both
the epithelial and oral areas are K10 and K19, respectively.
Color images available online at www.liebertonline.com/tec
FIG. 7. To determine the structure of a full construct without formation of the vermillion, a preliminary experiment was
performed in which the cells were not allowed to migrate and come into contact, being kept separated over the Alloderm when
submersed and using 1.2mM calcium medium to prevent cell migration. In this case, alveolar ridge cells were used in the oral
area. In (A) a panoramic view of the full 3D lip construct is shown, with skin seeded cells on the left and alveolar ridge cells on the
right. Cells did not migrate toward the center and the barrier area remained without cells. A magnified view of the structure and
keratin 10 expression of both epithelial and oral areas is shown in (B) and (C) respectively. This experiment illustrates the
possibilities of the technique in the formation of 3D muco-cutaneous constructs, where varied cell types can be simultaneously
seeded, or not, in the different compartments formed by the barrier. Color images available online at www.liebertonline.com/tec
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A final aspect to discuss is the fact that Alloderm is a
skin-derived substrate and has been repeatedly shown to
reproduce epidermal tissue structures that resemble kerati-
nized skin and oral mucosa. Our results indicate that, in vitro,
Alloderm also permits the differentiation and stratification of
nonkeratinized, buccal mucosa. The development of full au-
tologous mucosa equivalents with the inclusion of fibroblasts
was only recently reported.35 Other dermal substitutes for
development of nonkeratinized oral mucosa constructs have
been reported using collagen-based membranes.36
The testing of these 3D constructs in vivo could initially be
done by grafting the constructs into athymic (nude) rats to
allow integration with the underlying striated muscular bed
as previously done with mice25 to evaluate vascular in-
growth. It has been shown in clinical trials that use of the
Alloderm as a dermal substitute without the presence of
fibroblasts in keratinized oral mucosa repair is successful on
transplantation. The dermal component improves the han-
dling, intraoral placement, and stabilization of the graft at
the surgical site with limited scarring26 so we expect that our
new lip constructs will reproduce these results in vivo.
An important advantage of the technique presented is the
fact that the 3D lip constructs are manufactured in serum-
free medium modified to contain totally defined animal-free
supplements and without the use of feeder layers.17 This
culturing approach will allow grafting the 3D lip constructs,
back into autogenous human recipients with minimal risk of
cellular cross-contamination or immunological rejection.37
The approach presented in tissue engineering 3D lips will
have several advantages for the reconstruction of craniofacial
soft tissue injuries. In particular, the source of the cells to
develop the 3D skin lips constructs will come from small
punch biopsies from the oral mucosa and skin of the patient,
thus making the construct autochthonous.
In summary, our method is proposed as a general basis for
tissue engineering of lips and other M/C junctions. Like any
other first-time techniques, the one described here will re-
quire refinements and adjustments, particularly with the
creation of larger lip or other M/C constructs. Sealing of the
polymeric barrier can also be improved, particularly to de-
crease the pressure exerted on the AlloDerm during the ini-
tial preparation. Selection of PDMS was based on its
extensive use in medical systems, biocompatibility, ease of
manipulation and preparation, and lack of toxicity. Finding
alternative biomaterials to be used as temporary, self-
standing membranes would be an interesting option that we
are currently exploring.
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